Lipidomics studies on macrophages - RAW 264.7 cells treated with Kdo2-Lipid A and compactin
Introduction | Browse | Search | DownloadMouse-over the above links for more information
Treatment details
| LM ID | Analyte | Treatment | Time(hrs) | Sample ID | Value | Units |
|---|---|---|---|---|---|---|
| - | 1,2-DAG(33:1) | cPLA2i | 1.0 | BCD110605C28 | 1.63 | pmol/sample |
| - | 1,2-DAG(33:1) | cPLA2i | 1.0 | BCD110605C30 | 0.816 | pmol/sample |
| - | 1,2-DAG(33:1) | cPLA2i | 1.0 | BCD110605C29 | 0.3 | pmol/sample |
| - | 1,2-DAG(33:1) | cPLA2i | 20.0 | BCD110605C64 | 2.55 | pmol/sample |
| - | 1,2-DAG(33:1) | cPLA2i | 20.0 | BCD110605C66 | 1.29 | pmol/sample |
| - | 1,2-DAG(33:1) | cPLA2i | 20.0 | BCD110605C65 | 0.697 | pmol/sample |
| - | 1,2-DAG(33:1) | PLDi | 1.0 | BCD110605C16 | 1.39 | pmol/sample |
| - | 1,2-DAG(33:1) | PLDi | 1.0 | BCD110605C17 | 0.459 | pmol/sample |
| - | 1,2-DAG(33:1) | PLDi | 1.0 | BCD110605C18 | 0.145 | pmol/sample |
| - | 1,2-DAG(33:1) | PLDi | 20.0 | BCD110605C54 | 0.427 | pmol/sample |
| - | 1,2-DAG(33:1) | PLDi | 20.0 | BCD110605C52 | 0.906 | pmol/sample |
| - | 1,2-DAG(33:1) | PLDi | 20.0 | BCD110605C53 | 0.397 | pmol/sample |
| - | 1,2-DAG(33:1) | KDO+cPLA2i | 1.0 | BCD110605C32 | 0.648 | pmol/sample |
| - | 1,2-DAG(33:1) | KDO+cPLA2i | 1.0 | BCD110605C31 | 1.64 | pmol/sample |
| - | 1,2-DAG(33:1) | KDO+cPLA2i | 1.0 | BCD110605C33 | 0.843 | pmol/sample |
| - | 1,2-DAG(33:1) | KDO+cPLA2i | 20.0 | BCD110605C68 | 1.57 | pmol/sample |
| - | 1,2-DAG(33:1) | KDO+cPLA2i | 20.0 | BCD110605C69 | 1.47 | pmol/sample |
| - | 1,2-DAG(33:1) | KDO+cPLA2i | 20.0 | BCD110605C67 | 3.74 | pmol/sample |
| - | 1,2-DAG(33:1) | KDO+PLDi | 1.0 | BCD110605C19 | 1.56 | pmol/sample |
| - | 1,2-DAG(33:1) | KDO+PLDi | 1.0 | BCD110605C20 | 0.423 | pmol/sample |
| - | 1,2-DAG(33:1) | KDO+PLDi | 1.0 | BCD110605C21 | 0.334 | pmol/sample |
| - | 1,2-DAG(33:1) | KDO+PLDi | 20.0 | BCD110605C56 | 1.08 | pmol/sample |
| - | 1,2-DAG(33:1) | KDO+PLDi | 20.0 | BCD110605C57 | 0.901 | pmol/sample |
| - | 1,2-DAG(33:1) | KDO+PLDi | 20.0 | BCD110605C55 | 1.71 | pmol/sample |
| - | 1,2-DAG(33:1) | KDO+ATP+cPLA2i | 1.0 | BCD110605C37 | 4.26 | pmol/sample |
| - | 1,2-DAG(33:1) | KDO+ATP+cPLA2i | 1.0 | BCD110605C38 | 0.465 | pmol/sample |
| - | 1,2-DAG(33:1) | KDO+ATP+cPLA2i | 1.0 | BCD110605C39 | 0.781 | pmol/sample |
| - | 1,2-DAG(33:1) | KDO+ATP+cPLA2i | 20.0 | BCD110605C74 | 0.826 | pmol/sample |
| - | 1,2-DAG(33:1) | KDO+ATP+cPLA2i | 20.0 | BCD110605C75 | 2.41 | pmol/sample |
| - | 1,2-DAG(33:1) | KDO+ATP+cPLA2i | 20.0 | BCD110605C73 | 3.56 | pmol/sample |
| - | 1,2-DAG(33:1) | KDO+ATP+PLDi | 1.0 | BCD110605C25 | 4.12 | pmol/sample |
| - | 1,2-DAG(33:1) | KDO+ATP+PLDi | 1.0 | BCD110605C27 | 0.589 | pmol/sample |
| - | 1,2-DAG(33:1) | KDO+ATP+PLDi | 1.0 | BCD110605C26 | 0.399 | pmol/sample |
| - | 1,2-DAG(33:1) | KDO+ATP+PLDi | 20.0 | BCD110605C61 | 1.25 | pmol/sample |
| - | 1,2-DAG(33:1) | KDO+ATP+PLDi | 20.0 | BCD110605C62 | 0.268 | pmol/sample |
| - | 1,2-DAG(33:1) | KDO+ATP+PLDi | 20.0 | BCD110605C63 | 0.76 | pmol/sample |
| - | 1,2-DAG(33:1) | KDO + ATP | 1.0 | BCD110605C15 | 0.41 | pmol/sample |
| - | 1,2-DAG(33:1) | KDO + ATP | 1.0 | BCD110605C14 | 0.646 | pmol/sample |
| - | 1,2-DAG(33:1) | KDO + ATP | 1.0 | BCD110605C13 | 2.98 | pmol/sample |
| - | 1,2-DAG(33:1) | KDO + ATP | 20.0 | BCD110605C49 | 4.07 | pmol/sample |
| - | 1,2-DAG(33:1) | KDO + ATP | 20.0 | BCD110605C50 | 0.491 | pmol/sample |
| - | 1,2-DAG(33:1) | KDO + ATP | 20.0 | BCD110605C51 | 1.76 | pmol/sample |
| - | 1,2-DAG(33:1) | KDO | 1.0 | BCD110605C08 | 0.399 | pmol/sample |
| - | 1,2-DAG(33:1) | KDO | 1.0 | BCD110605C07 | 3.49 | pmol/sample |
| - | 1,2-DAG(33:1) | KDO | 1.0 | BCD110605C09 | 0.878 | pmol/sample |
| - | 1,2-DAG(33:1) | KDO | 20.0 | BCD110605C45 | 1.3 | pmol/sample |
| - | 1,2-DAG(33:1) | KDO | 20.0 | BCD110605C44 | 0.995 | pmol/sample |
| - | 1,2-DAG(33:1) | KDO | 20.0 | BCD110605C43 | 6.55 | pmol/sample |
| - | 1,2-DAG(33:1) | C | 0.0 | BCD110605C03 | 1.1 | pmol/sample |
| - | 1,2-DAG(33:1) | C | 0.0 | BCD110605C01 | 4.05 | pmol/sample |